Tackling Chronic Kidney Disease in Diabetic Patients with Finerenone
Trends in pharmacological sciences(2022)
Abstract
STRUCTURE: (−)-Finerenone is a nonsteroidal selective mineralocorticoid receptor (MR) antagonist. The core 1,6-naphthyridine core in red; (S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-didydro-1,6-naphthyridine (core in red)-3-carboxamide.
MoreTranslated text
Key words
Mineralocorticoid Receptor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined